Oxford Health BRC is supporting its second Academic Paper Writing Retreat for Nurses. The retreat will take place at the Department of Psychiatry on 7th, 9th and 10th March 2020….
Calcium ions play a critical role in how brain cells work, and it has long been suspected that an abnormality in calcium might contribute to bipolar disorder. However, findings have been variable and no conclusions could be drawn.
Analysis published in The Lancet has shown that there is significant difference in the way antipsychotic drugs affect body weight and levels of sugar, cholesterol and other fats in the blood.
Register to attend our workshop on 10 December 2019! Patient and Public Involvement (PPI) is an important element of most research funding applications, but how can you get it right…
Memory, coping strategies and resilience immediately following a loss have been shown to predict the path of a bereaved person’s grief according to new research. The study, published in the…
Results of a network meta-analysis published in The Lancet this month will aid clinicians in balancing the risks and benefits of the antipsychotic drugs they are prescribing to treat schizophrenia….
Join our focus group to help develop a new research project! About the research The anonymous use of health records for mental health research has the potential to lead to…
Are you interested in dementia research? Do you have experience of caring for or supporting someone with dementia? Do you want to share your views and experience to develop a…
This new course ran for the first time in January 2019, with an engaging and thought-provoking programme of talks, tours of facilities and group discussions. Feedback from participants was uniformly…
Patients, carers and advocates say better evidence is needed on the safety of ketamine for depression after long-term use, and that those prescribed it must be closely monitored. These are…
Oxford Health BRC is supporting a three day Academic Paper Writing Retreat for Nurses planned for this September. The retreat, also sponsored by the Oxford cognitive health Clinical Research Facility…
A new clinical trial beginning on 1st July is testing a virtual reality (VR) based psychological therapy for people with severe mental health difficulties. gameChange is the largest ever clinical…
Analysis published earlier this month in The Lancet Psychiatry shows that a lower dose of the most commonly used second-generation antidepressants achieves the best balance of effectiveness and tolerability in…
Cristal Health, a new spinout from Oxford, has been developed as a sustainable way to accelerate the UK-CRIS programme. The UK-CRIS network operates a managed service for secure access to…
Do you have experience of treatment resistant depression either as a patient or a carer? Are you interested in medical research? Would you like to share your experience and interest…
Experts from the Oxford Health Biomedical Research Centre (BRC) and Clinical Research Facility (CRF) came together on Monday 20th May to showcase their latest research at our annual mental health…
Oxford Health Biomedical Research Centre has launched an international survey to gather information about the side effects of antidepressants. Aimed at both patients and prescribers, results of the survey will…
We are pleased to invite UK and EU applications for a doctoral degree within the Oxford Health Biomedical Research Centre and the Centre for Evidence Based Mental Health, in the Department of Psychiatry of the University of Oxford. The doctoral degree will start in October 2019.
Are you interested in mental health and dementia research? Join our open day to find out about our current work! When: Monday 20 May 2019, 10am – 2pm Where: St…
The Early Psychosis Research Group is looking for patient and carer members to join their group! We are a research group from the University of Oxford Department of Psychiatry who…
